Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

Vaccine

Volumn 17, Issue 6, 1999, Pages 589-596

  Hanke, Tomáš ^a   Neumann, Veronica C ^b   Blanchard, Tom J ^c   Sweeney, Paul ^b   Hill, Adrian V S ^a   Smith, Geoffrey L ^c   McMichael, Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b PowderJect Vaccines Inc   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Combined vaccination; CTL polyepitope; Gene gun

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; IMMUNOSTIMULATION; MACACA; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

AIDS VACCINES; ANIMALS; BIOLISTICS; EPITOPES, T-LYMPHOCYTE; FEMALE; HIV; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, COMBINED; VACCINES, DNA;

EID: 0033547972     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00238-2     Document Type: Article

References (48)

1. Zinkernagel R.M., Doherty P.C. H-2 compatibility requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med. 141:1975;1427-1436.
2. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., Gotch F., Ariyoshi K., Hallam N., Kroll J.S., Froebel K., McMichael A. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860-861.
3. Carmichael A., Jin X., Sissons P., Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med. 177:1993;249-256.
4. Borrow P., Lewicki H., Hahn B.E., Shaw G.M., Oldstone M.B. Virus-specific CD8+ CTL activity associated with control of viremia in primary HIV-1 infection. J Virol. 68:1994;6103-6110.
5. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLoed G., Borkowsky W., Farthing C., Ho D.D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 68:1994;4650-4655.
6. Rinaldo C., Huang X.L., Fan Z.F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M.et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load associated with lack of disease in HIV-1 infected long-term nonprogressors. J Virol. 69:1995;5838-5842.
7. Rowland-Jones S., Sutton J., Ariyoshi K., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., McMichael A., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:1995;59-64.
8. Klein M.R., van Baalen C.A., Holwerda A.M., Kerkhof Garde S.R., Bende R.J., Keet I.P.M., Eeftinck-Schattenkerk J.-K.M., Osterhaus A.D.M.E., Schuitemaker H., Miedema F. Kinetics of gag-specific cytotoxic T-lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med. 181:1995;1365-1372.
9. Borrow P., Lewicki H., Wei X., Horwitz M.S., Peffer N., Meyers H., Nelson J.A., Gairin J.E., Hahn B.H., Oldstone M.B.A., Shaw G.M. Antiviral pressure exerted by HIV-1-specific cytotoxic T-lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3:1997;205-211.
10. Goulder P.J.R., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., McMichael A.J., Rowland-Jones S. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3:1997;212-217.
11. Sidney J., Grey H.M., Kubo R.T., Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today. 17:1996;261-266.
12. Hanke T., Schneider J., Gilbert S.G., Hill A.V.S., McMichael A. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. Vaccine. 16:1998;426-435.
13. Hanke T., Blanchard T.J., Schneider J., Ogg G.S., Tan R., Becker M.S.C., Gilbert S.G., Hill A.V.S., Smith G.L., McMichael A. Immunogenicities of intravenous and intramuscular administrations of MVA-based multi-CTL epitope vaccine for HIV in mice. J Gen Virol. 79:1998;83-90.
14. Mayr A., Stickl H., Muller H.K., Danner K., Singer H. Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwachten Organismus. Zentralbl Bakt Hyg I (Abt Orig B). 167:1978;375-390.
15. Hanke T., Blanchard T.J., Schneider J., Hannan C.M., Becker M., Gilbert S.C., Hill A.V.S., Smith G.L., McMichael A. Enhancement of MHC class I-restricted peptide-specific T-cell induction by a DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439-445.
16. + T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med. 4:1998;397-402.
17. Haynes J.R., Fuller D.H., McCabe D., Swain W.F., Widera G. Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization. Adv Drug Delivery Rev. 21:1996;3-18.
18. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
19. Eisenbraun M.D., Fuller D.H., Haynes J.R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:1993;791-797.
20. Fuller D.H., Haynes J.R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses. 10:1994;1141-1433.
21. Barry M.A., Lai W.C., Johnston S.A. Protection against mycoplasma infection using expression-library immunization. Nature. 377:1995;632-634.
22. Takahashi H., Cohen J., Hosmalin A., Cease K.B., Houghten R., Cornette J.L., DeLisi C., Moss B., Germain R.N., Berzofsky J.A. An immunodomonant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility molecule-restricted murine cytotoxic T-lymphocytes. Proc Natl Acad Sci. USA. 85:1988;3105-3109.
23. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T-cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 341:1989;323-326.
24. Yasutomi Y., Robinson H.L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J.I., Voss G., Manson K., Wyand M., Letvin N.L. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol. 70:1996;678-681.
25. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.-E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., Shiver J.W. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA. 94:1997;9378-9383.
26. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with DNA vaccine to the haemagglutinin. Vaccine. 12:1994;1495.
27. Fuller D.H., Murphey C.M., Clements J., Barnett S., Haynes J.R. Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J Med Primatol. 25:1996;236-241.
28. Fuller D.H., Murphy-Corb M., Barnett S., Steimer K., Haynes J.R. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine. 15:1997;924-926.
29. Fuller D.H., Simpson L., Cole K.S., Clements J.E., Panicali D.L., Montelaro R.C., Murphey-Corb M., Haynes J.R. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol. 75:1997;389-396.
30. Pertmer T.M., Eisenbraun M.D., McCabe D., Prayaga S.K., Fuller D.H., Haynes J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T-lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
31. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol. 70:1996;3978-3991.
32. Torres C.A., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol. 158:1997;4529-4532.
33. Doe B., Selby M., Barnett S., Baenzinger J., Walker C.M. Induction of cytotoxic T-lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA. 93:1996;8578-8583.
34. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med. 184:1996;1555-1560.
35. Iwasaki A., Torres C.A., Ohashi P.S., Robinson H.L., Barber B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol. 159:1997;11-14.
36. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene gun-mediated inoculations. Proc Natl Acad Sci USA. 90:1993;11478-11482.
37. Yokoyama M., Zhang J., Whitton J.L. DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol Med Microbiol. 14:1996;221-230.
38. Yokoyama M., Hassett D.E., Zhang J., Whitton J.L. DNA immunization can stimulate florid local inflamation, and the antiviral immunity induced varies depending on injection site. Vaccine. 15:1997;553-560.
39. Stewart M.J., Plautz G.E., Del Buono L., Yang Z.Y., Xu L., Gao X., Huang L., Nabel E.G., Nabel G.J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Human Gene Ther. 3:1992;267-275.
40. Klavinskis L.S., Gao L., Barnfield C., Lehner T., Parker S. Mucosal immunization with DNA-liposome complexes. Vaccine. 15:1997;818-820.
41. Jones D.H., Corris S., McDonald S., Clegg J.C.S., Farrar G.H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:1997;814-817.
42. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T-helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 158:1997;2278-2284.
43. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., Robinson H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology. 209:1995;147-154.
44. Leong KH, Ramsay AJ, Ramshaw IA, Morin J, Robinson HL, Boyle DB. Generation of enhanced immune responses by consecutive immunization with DNA and recombinant fowl poxvirus. In: Brown, Chanock, Ginsberg, editors. Vaccines 95. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1995.
45. Lu S., Santoro J.C., Fuller D.H., Haynes J.R., Robinson H.L. Use of DNAs expressing HIV-1 particles to raise antibody responses in mice. Virology. 209:1995;147-154.
46. Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., Walker C.M., Steimer K.S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 subunit. Vaccine. 15:1997;869-973.
47. Daniel M.D., Mazzara G.P., Simon M.A., Sehgal P.K., Kodama T., Panicali D.L., Desrosiers R.C. High titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res Hum. Retroviruses. 10:1994;839-851.
48. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc Natl Acad Sci USA. 90:1993;11478-11482.